ClinVar Miner

Submissions for variant NM_003060.4(SLC22A5):c.1249A>G (p.Met417Val)

gnomAD frequency: 0.00365  dbSNP: rs139775414
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000555770 SCV000632519 benign Renal carnitine transport defect 2024-01-31 criteria provided, single submitter clinical testing
GeneDx RCV001696988 SCV000731064 benign not provided 2020-08-19 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 24123366)
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000602546 SCV001363925 benign not specified 2019-03-11 criteria provided, single submitter clinical testing Variant summary: SLC22A5 c.1249A>G (p.Met417Val) results in a conservative amino acid change located in the Major facilitator superfamily domain of the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0012 in 277134 control chromosomes, predominantly at a frequency of 0.012 within the African subpopulation in the gnomAD database, including 2 homozygotes. The observed variant frequency within African control individuals in the gnomAD database is approximately 3-folds higher than the estimated maximal expected allele frequency for a pathogenic variant in SLC22A5 causing Systemic Primary Carnitine Deficiency phenotype (0.0046), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African origin. To our knowledge, no occurrence of c.1249A>G in individuals affected with Systemic Primary Carnitine Deficiency and no experimental evidence demonstrating its impact on protein function have been reported. Two ClinVar submissions from clinical diagnostic laboratories (evaluation after 2014) cites the variant once as likely benign and once as benign. Based on the evidence outlined above, the variant was classified as benign.
Genome-Nilou Lab RCV000555770 SCV002055878 benign Renal carnitine transport defect 2021-07-15 criteria provided, single submitter clinical testing
Giacomini Lab, University of California, San Francisco RCV000555770 SCV002576600 likely benign Renal carnitine transport defect 2022-10-03 criteria provided, single submitter research
CeGaT Center for Human Genetics Tuebingen RCV001696988 SCV004011618 benign not provided 2023-04-01 criteria provided, single submitter clinical testing SLC22A5: BP4, BS1, BS2

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.